Mounjaro, a relatively novel drug approved by the FDA in May 2023, is generating significant excitement within the medical community for its ability to treat Type 2 diabetes. While not a cure, Mounjaro appears to be offering substantial benefits in managing blood sugar levels and reducing the need for other get more info medications. Early trials s